Research Article

Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway

Figure 9

Rab22a regulated the EMT process of thyroid cancer cells via PI3K/AKT/mTOR signaling pathway. Western blot analysis showed that the expression of EMT-related proteins upon Rab22a transfection was changed after treatment with PI3K inhibitors (a, b). Statistical data were the mean ± SD of the three repeated independent trials: , , and .
(a)
(b)